News about "Glenmark Pharmaceuticals"

Glenmark Pharmaceuticals Introduces Latanoprost Ophthalmic Solution

Glenmark’s Latanoprost Ophthalmic Solution, 0.005 percent (0.05 mg/mL) is bioequivalent and therapeutically equivalent to the reference listed drug, Xalatan®2 Ophthalmic Solution, 0.005 percent of Upjohn US 2 LLC.

Glenmark Pharmaceuticals | 18/02/2025 | By Aishwarya

Glenmark Pharmaceuticals Unveils Generic Anticoagulant Injectable Emulsion

Glenmark's Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules is bioequivalent and therapeutically equivalent to the reference listed drug, Vitamin K1 Injectable Emulsion USP, 10 mg/mL of Hospira, Inc., ANDA 087955.

Glenmark Pharmaceuticals | 24/01/2025 | By Aishwarya

Glenmark Introduces Lacosamide Oral Solution

Glenmark’s Lacosamide Oral Solution, 10 mg/mL is bioequivalent and therapeutically equivalent to the reference listed drug, Vimpat Oral Solution, 10 mg/mL of UCB, Inc.

Glenmark Pharmaceuticals | 16/12/2024 | By Aishwarya

Glenmark Gets ANDA Approval for Topiramate Capsules

Glenmark Pharmaceuticals Ltd. has been granted final approval by the United States Food and Drug Administration (US FDA) for Topiramate Capsules USP, 15 mg and 25 mg.

Glenmark Pharmaceuticals | 22/07/2024 | By Aishwarya |  221

Glenmark and IADVL Raise Awareness Campaign to Support Vitiligo Patients in India

Glenmark Pharmaceuticals Ltd. has joined forces with The Indian Association of Dermatologists, Venereologists, and Leprologists (IADVL), to unveil postcards & Calendars aimed at raising awareness.

Glenmark Pharmaceuticals | 28/06/2024 | By Aishwarya |  106

Glenmark Secures ANDA Approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution

Glenmark Pharmaceuticals Ltd. has received final approval from the United States Food and Drug Administration (US FDA) for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2 percent|0.5 percent.

Glenmark Pharmaceuticals | 18/05/2024 | By Aishwarya |  140

Glenmark Gets ANDA Approval for Acetaminophen and Ibuprofen Tablets

Glenmark Pharmaceuticals Ltd. has received final approval from the United States Food and Drug Administration (US FDA) for Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC), determined by the FDA.

Glenmark Pharmaceuticals | 29/04/2024 | By Aishwarya |  284

Glenmark Pharmaceuticals in Process of Recalling 1,200 Bottles of Subpotent Hypertension Drug in USA

The affected lot has been manufactured at the Goa plant of the Mumbai-based drug firm and then supplied to Glenmark Pharmaceuticals Inc, USA, the USFDA said.

Glenmark Pharmaceuticals | 29/08/2023 | By Manvi |  458

Glenmark Pharma settles drug pricing case with US Department of Justice

Glenmark Pharma settles drug pricing case with US Department of Justice

Glenmark Pharmaceuticals | 24/08/2023 | By Sudeep Soparkar |  389

Glenmark, Cediprof in agreement for US FDA-approved mixed amphetamines tabs

Glenmark expects to commence distribution of the product in the US during the second half of 2023
<br />

Glenmark Pharmaceuticals | 11/03/2023 | By Sudeep Soparkar |  469